Special Drug Use Investigation for PAXIL Social Anxiety Disorder (Long-term).

Trial Profile

Special Drug Use Investigation for PAXIL Social Anxiety Disorder (Long-term).

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2014

At a glance

  • Drugs Paroxetine (Primary)
  • Indications Social phobia
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 01 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 07 Jun 2013 Planned End Date changed from 1 Oct 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.
    • 22 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top